EUVIMEDEUVIMED entdecken
Crossref

Lack of RBC transfusion independence by Day 30 following allogeneic hematopoietic stem cell transplant strongly predicts inferior survival and high non‐relapse mortality in acute myeloid leukemia patients

Shan Yuan iD, Dongyun Yang, Ryotaro Nakamura, Monzr M Al Malki, Amandeep Salhotra, Michelle Afkhami, Shirong Wang

Transfusion · 2024-02 · 64 (2) · 255-280

DOI: 10.1111/trf.17714 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, online erschienen am 15.01.2024. Verfasst von Shan Yuan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Transfusion Medicine, Department of Pathology, City of Hope National Medical Center, Duarte, California, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Leukemia, Myeloid, Acute, Graft vs Host Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Studies have suggested that acute myeloid leukemia (AML) patients with incomplete hematologic recovery undergoing allogeneic stem cell transplantation (allo‐HSCT) had inferior overall survival (OS). Study Design and Methods This single‐center, retrospective study of AML patients evaluated the relationship between red blood cell (RBC) and platelet (PLT) transfusion requirements during the first 30 days and long‐term outcomes after allo‐HSCT through multivariate analyses.

Results

A total of 692 AML patients received peripheral blood stem cells (89.2%), marrow (5.6%), or umbilical cord (5.2%) from matched related (37.4%), unrelated (49.1%), or haploidentical (8.2%) donors in 2011–2017. Transfusion requirements during the first 30 days for RBC (89.5% transfused, median 3, range 1–18 units) or PLT (98.2% transfused, median 6, range 1–144 units) were variable. By Day 30, 56.7% (95% confidence interval [CI]: 52.8–60.3%) and 86.1% (95% CI: 83.2–88.5%) had achieved RBC and PLT transfusion independence, respectively. Median follow‐up among survivors ( n = 307) was 7.1 years (range: 2.7–11.8). Lack of RBC transfusion independence by Day 30 was strongly and independently associated with worse 5‐year OS (39.2% vs. 59.6%, adjusted hazard ratio [HR] 1.83, 95% CI: 1.49–2.25), leukemia‐free survival (35.8% vs. 55.5%, HR = 1.75, 95% CI: 1.43–2.14), and NRM (29.7% vs. 13.7%, HR = 2.05, 95% CI: 1.45–2.89) ( p < .001). There was no difference in relapse rates among patients who achieved or did not achieve RBC ( p = .34) or PLT ( p = .64) transfusion independence.

Conclusion

Prolonged RBC dependence predicted worse survival and NRM rates, but not increased relapse. Posttransplant surveillance of such patients should be adjusted with more attention to non‐relapse complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteGraft vs Host DiseaseHumansRetrospective StudiesErythrocyte TransfusionRecurrence

Stichwörter der Autor:innen

RBC transfusionplatelet transfusiontransplantation-stem cell

Autor:innen und Institutionen

  • Division of Transfusion Medicine, Department of Pathology, City of Hope National Medical Center, Duarte, California, USA.
  • Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, California, USA.
  • Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.
  • Division of Molecular Pathology & Therapy Biomarkers, Department of Pathology, City of Hope National Medical Center, Duarte, California, USA.

ORCID-Profile: Shan Yuan

Zitieren

APA

Yuan, S., Yang, D., Nakamura, R., Al Malki, M. M., Salhotra, A., Afkhami, M., & Wang, S. (2024). Lack of RBC transfusion independence by Day 30 following allogeneic hematopoietic stem cell transplant strongly predicts inferior survival and high non‐relapse mortality in acute myeloid leukemia patients. Transfusion, 64(2), 255-280. https://doi.org/10.1111/trf.17714

Vancouver

Yuan S, Yang D, Nakamura R, Al Malki MM, Salhotra A, Afkhami M, et al. Lack of RBC transfusion independence by Day 30 following allogeneic hematopoietic stem cell transplant strongly predicts inferior survival and high non‐relapse mortality in acute myeloid leukemia patients. Transfusion. 2024;64(2):255-280. doi:10.1111/trf.17714

BibTeX
@article{Yuan2024,
  author = {Yuan, Shan and Yang, Dongyun and Nakamura, Ryotaro and Al Malki, Monzr M and Salhotra, Amandeep and Afkhami, Michelle and Wang, Shirong},
  title = {Lack of RBC transfusion independence by Day 30 following allogeneic hematopoietic stem cell transplant strongly predicts inferior survival and high non‐relapse mortality in acute myeloid leukemia patients},
  journal = {Transfusion},
  year = {2024},
  volume = {64},
  number = {2},
  pages = {255--280},
  doi = {10.1111/trf.17714}
}
Kostenlos starten →